Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Peter Evan Harwin

Director at Crescent Biopharma, Inc. (CBIO); Director at Zenas BioPharma, Inc. (ZBIO)

Purchase track record

Below average. Based on 2 purchases with a full 90 days of price history.

15
Avg. 90-day return-24.6%
vs. S&P 500-25.9%
Beat the market0%
Paper profit on buys+$4.7M
Total bought / sold$24.2M / $0

Reported trades

Filed Stock Type Shares Price Value Since
Dec 8SEC CBIOCrescent Biopharma, Inc. Buy 1,360,0002,747,866 held (+98%) $13.41 $18.2M +11.2%
Oct 9SEC ZBIOZenas BioPharma, Inc. Buy 316,2192,209,025 held (+17%) $19.00 $6.0M +43.5%
  • Buy

    Director Peter Evan Harwin bought $18.2M of CBIO at $13.41 — first open-market purchase in our records; raises the stake by 98%.

  • Buy

    Director Peter Evan Harwin bought $6.0M of ZBIO at $19.00 — first open-market purchase in our records.